In wake of Q2 revenue drop, Charles River cuts 3% of workforce
WEBSep 12, 2024 · In the wake of a second quarter that saw revenues decline by 3.2%, contract research organization Charles River Laboratories is laying off 3% of its workforce, a spokesperson confirmed to Fierce ...
Charles River cuts 2024 forecast on lower demand for drug ...
WEBAug 7, 2024 · (Reuters) - Contract drug developer Charles River Laboratories cut its annual forecasts on Thursday as it warned of worsening demand from drugmakers and a persistently low appetite for clinical...
Charles River Laboratories Announces Second-Quarter 2024 ...
WEBAug 7, 2024 · WILMINGTON, Mass. -- (BUSINESS WIRE)--Aug. 7, 2024-- Charles River Laboratories International, Inc. (NYSE: CRL) today reported its results for the second quarter of 2024. For the quarter, revenue was $1.03 billion, a decrease of 3.2% from $1.06 billion in the second quarter of 2023.
Charles River looks to help bring Ori's CGT platform forward
WEB2 days ago · Overall, IRO was able to hit 51% CAR+ expression and 2.1 billion total CAR+ cells in seven to eight days versus 1.6 billion total CAR+ cells using Charles Rivers’ legacy tech. Looking ahead, Ori ...
News Releases | Charles River Laboratories International, Inc.
WEBCharles River Laboratories Announces Strategic Lentiviral Vector Manufacturing Collaboration with Gates Institute at University of Colorado Anschutz Medical Campus. 06/17/24. Charles River and Captain T Cell Announce Plasmid DNA and Viral Vector Manufacturing Alliance for Gene-Modified Cell Therapy. 06/11/24.
Charles River Laboratories International, Inc. (CRL) Latest ...
WEBGet the latest Charles River Laboratories International, Inc. (CRL) stock news and headlines to help you in your trading and investing decisions.
Charles River Laboratories Announces Fourth-Quarter and Full ...
WEBFeb 16, 2022 · WILMINGTON, Mass. -- (BUSINESS WIRE)--Feb. 16, 2022-- Charles River Laboratories International, Inc. (NYSE: CRL) today reported its results for the fourth-quarter and full-year 2021 and reaffirmed guidance for 2022. For the quarter, revenue was $905.1 million, an increase of 14.4% from $791.0 million in the fourth quarter of 2020.
Charles River Laboratories International, Inc. (CRL) Stock ...
WEBFind the latest Charles River Laboratories International, Inc. (CRL) stock quote, history, news and other vital information to help you with your stock trading and investing.
Charles River cuts 2024 forecast on lower demand for drug ...
WEBAug 7, 2024 · Charles River and its peers have been grappling with soft demand for their services from biotech clients due to a funding crunch in the past year amid a high-interest-rate environment.
Cyanobacteria bloom prompts public health advisory for ...
WEB19 hours ago · A familiar issue at bodies of water around the state, the cyanobacteria bloom in the Charles River is the first such bloom in the river since 2020, according to the watershed association.
Skip to content